An2 Therapeutics, Inc.
ANTX
Revenue
0.00
0.000.00%
-Assets
92.09M
▼-5.60M▼-5.73%
3 Months ChangeLiabilities
10.24M
▲221.00k▲2.21%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-19
Form 8-K
ID: 0001193125-24-202430
2024-08-13
Form 10-Q
ID: 0000950170-24-096243
2024-08-13
Form 8-K
ID: 0000950170-24-096173
2024-08-08
Form 8-K
ID: 0001193125-24-197047
2024-06-24
Form 8-K
ID: 0001193125-24-166938
2024-05-14
Form 10-Q
ID: 0000950170-24-059556
2024-05-14
Form 8-K
ID: 0000950170-24-059527
2024-03-28
Form 8-K
ID: 0000950170-24-038055
2024-02-12
Form 8-K
ID: 0001193125-24-031008
2023-11-09
Form 10-Q
ID: 0000950170-23-062081